Exploring targeted therapy of osteosarcoma using proteomics data
© 2017 Chaiyawat et al. Despite multimodal therapeutic treatments of osteosarcoma (OS), some patients develop resistance to currently available regimens and eventually end up with recurrent or metastatic outcomes. Many attempts have been made to discover effective drugs for improving outcome; howeve...
Saved in:
Main Authors: | Chaiyawat P., Settakorn J., Sangsin A., Teeyakasem P., Klangjorhor J., Soongkhaw A., Pruksakorn D. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85011976859&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40754 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Exploring targeted therapy of osteosarcoma using proteomics data
by: Parunya Chaiyawat, et al.
Published: (2018) -
Exploring targeted therapy of osteosarcoma using proteomics data
by: Parunya Chaiyawat, et al.
Published: (2018) -
In vitro drug sensitivity (IDS) of patient-derived primary osteosarcoma cells as an early predictor of the clinical outcomes of osteosarcoma patients
by: Jeerawan Klangjorhor, et al.
Published: (2020) -
Expression patterns of class i histone deacetylases in osteosarcoma: A novel prognostic marker with potential therapeutic implications
by: Parunya Chaiyawat, et al.
Published: (2018) -
Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2019)